Afrezza, Insulin Inhaler Therapy For Diabetes, Succeeds In Studies
Category: WELLNESS
Afrezza is the flagship product of MannKind, whose shares have risen nearly 50 percent over the past three months in anticipation
By Reuters, Reuters, 2013-08-14